See All Slides - tctmd.com

Slides

Presentation TCT 2013

CHAMPION PHOENIX IPST: Implications of Intraprocedural Stent Thrombosis During PCI from a Prospective, Randomized Trial of a Potent Intravenous ADP Antagonist vs. a Standard Ora...

Presenter: Philippe Généreux

October 28, 2013

Presentation TCT 2013

Update: Neovasc Tiara

Presenter: Shmuel Banai

October 28, 2013

Presentation TCT 2013

Safety and Performance of Urinary Bladder Electrical Stimulation in Acute Decompensated Heart Failure

Presenter: Andrejs Erglis

October 28, 2013

Presentation TCT 2013

Evidence Synthesis and Lessons Learned: The Nordic Bifurcation Trials

Presenter: Leif Thuesen

October 28, 2013

Presentation TCT 2013

Beyond the Coronaries: Transradial Intervention for Peripheral and Structural Heart Disease

Presenter: Rajiv Gulati

October 28, 2013

Presentation TCT 2013

Proactive Measures Have Reduced Major Vascular Complications After TAVR to < 5%: The Vancouver Experience

Presenter: John Webb

October 28, 2013

Presentation TCT 2013

Restenosis after Left Main PCI: Frequency, Patterns and Treatment (with Case Vignettes)

Presenter: Adrian Banning

October 28, 2013

Presentation TCT 2013

Who are the Right Patients for MitraClip Therapy in Today's Practice? Interventional Perspectives

Presenter: Paul Grayburn

October 28, 2013

Presentation TCT 2013

Con

Presenter: Paul Teirstein

October 28, 2013

Presentation TCT 2013

Frequency and Time Course of DES Restenosis and Stent Thrombosis: Latest Insights from Randomized Trials and the "Real World"

Presenter: Robert Byrne

October 28, 2013

Advertisement

Slides

CHAMPION PHOENIX IPST: Implications of Intraprocedural Stent Thrombosis During PCI from a Prospective, Randomized Trial of a Potent Intravenous ADP Antagonist vs. a Standard Ora...

Update: Neovasc Tiara

Safety and Performance of Urinary Bladder Electrical Stimulation in Acute Decompensated Heart Failure

Evidence Synthesis and Lessons Learned: The Nordic Bifurcation Trials

Beyond the Coronaries: Transradial Intervention for Peripheral and Structural Heart Disease

Proactive Measures Have Reduced Major Vascular Complications After TAVR to < 5%: The Vancouver Experience

Restenosis after Left Main PCI: Frequency, Patterns and Treatment (with Case Vignettes)

Who are the Right Patients for MitraClip Therapy in Today's Practice? Interventional Perspectives

Con

Frequency and Time Course of DES Restenosis and Stent Thrombosis: Latest Insights from Randomized Trials and the "Real World"

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content